McGee J - Search Results

1

Rates of genetic consultation in high-grade serous ovarian cancer patients in the era of PARP inhibitor therapy: A population-based study.

Brent SE, McGee J, Vicus D, Kim R, Eisen A, Wilton AS, Gien LT. Brent SE, et al. Among authors: mcgee j. Int J Gynaecol Obstet. 2024 Jan 29. doi: 10.1002/ijgo.15391. Online ahead of print. Int J Gynaecol Obstet. 2024. PMID: 38284267

2

Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers.

McGee J, Kotsopoulos J, Lubinski J, Lynch HT, Rosen B, Tung N, Kim-Sing C, Karlan B, Foulkes WD, Ainsworth P, Ghadirian P, Senter L, Eisen A, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. McGee J, et al. Obesity (Silver Spring). 2012 Jun;20(6):1288-92. doi: 10.1038/oby.2011.394. Epub 2012 Jan 19. Obesity (Silver Spring). 2012. PMID: 22262156 Free article.

3

Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario.

McGee J, Panabaker K, Leonard S, Ainsworth P, Elit L, Shariff SZ. McGee J, et al. Int J Gynecol Cancer. 2017 Mar;27(3):437-443. doi: 10.1097/IGC.0000000000000907. Int J Gynecol Cancer. 2017. PMID: 28072594 Free PMC article.

4

Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer: A Multi-institutional Cohort Study.

May T, Altman A, McGee J, Lu L, Xu W, Lane K, Ghatage P, Rosen B. May T, et al. Among authors: mcgee j. Int J Gynecol Cancer. 2018 Jun;28(5):925-931. doi: 10.1097/IGC.0000000000001244. Int J Gynecol Cancer. 2018. PMID: 29621126

5

Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?

Velker V, D'Souza D, Prefontaine M, McGee J, Leung E. Velker V, et al. Among authors: mcgee j. Int J Gynecol Cancer. 2016 Mar;26(3):491-6. doi: 10.1097/IGC.0000000000000643. Int J Gynecol Cancer. 2016. PMID: 26825823

6

A Population-Based Assessment of Urologic Procedures and Operations After Surgery or Pelvic Radiation for Cervical Cancer.

Welk B, Wallis C, D'Souza D, McGee J, Nam RK. Welk B, et al. Among authors: mcgee j. Int J Gynecol Cancer. 2018 Jun;28(5):989-995. doi: 10.1097/IGC.0000000000001266. Int J Gynecol Cancer. 2018. PMID: 29664839

7

Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process.

McGee J, Peart TM, Foley N, Bertrand M, Prefontaine M, Sugimoto A, Ettler H, Welch S, Panabaker K. McGee J, et al. J Oncol. 2019 Apr 2;2019:6029097. doi: 10.1155/2019/6029097. eCollection 2019. J Oncol. 2019. PMID: 31061661 Free PMC article.

8

Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data.

Hurry M, Hassan S, Seung SJ, Walton RN, Elnoursi A, McGee JD. Hurry M, et al. J Health Econ Outcomes Res. 2021 Dec 9;8(2):114-121. doi: 10.36469/jheor.2021.29145. eCollection 2021. J Health Econ Outcomes Res. 2021. PMID: 34993257 Free PMC article.

9

Complication Rates after Endometrial Ablation in Ontario: A Cohort Analysis of 76 446 Patients.

Ilnitsky S, McClure A, Vilos G, Vilos A, AbuRafea B, Vinden C, McGee J. Ilnitsky S, et al. Among authors: mcgee j. J Minim Invasive Gynecol. 2021 Nov;28(11):1935-1940.e4. doi: 10.1016/j.jmig.2021.05.003. Epub 2021 May 13. J Minim Invasive Gynecol. 2021. PMID: 33992798

10

Examining the Diagnostic Yield of Tumour Testing and Qualifying Germline Concordance for Hereditary Cancer Variants in Patients with High-Grade Serous Carcinoma.

Goebel EA, Kerkhof J, Dzyubak O, McLachlin CM, McGee J, Sadikovic B. Goebel EA, et al. Among authors: mcgee j. Genes (Basel). 2022 Aug 6;13(8):1398. doi: 10.3390/genes13081398. Genes (Basel). 2022. PMID: 36011309 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

821 results

Search Page